Sunitinib Malate recalls

The FDA has published 3 recalls involving Sunitinib Malate since 2023. The latest was reported on 11 Dec 2024. Most were for packaging defects. AvKARE has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2023
Last 12 months0reported
Class I00% of total
Ongoing2latest 11 Dec 2024

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why sunitinib malate is recalled

By year

Ongoing sunitinib malate recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISunitinib Malate Capsules, 25 mg recalled by AvKARESunitinib MalateAvKAREPackaging DefectsNationwide
DrugCLASS IISunitinib Malate Capsules, 5 mg recalled by AvKARESunitinib MalateAvKAREPackaging DefectsNationwide

All sunitinib malate recalls, newest first

3 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISunitinib Malate Capsules, 25 mg recalled by AvKARESunitinib MalateAvKAREPackaging DefectsNationwide
DrugCLASS IISunitinib Malate Capsules, 5 mg recalled by AvKARESunitinib MalateAvKAREPackaging DefectsNationwide
DrugCLASS IISunitinib Malate Capsules, 5 mg recalled by Teva Pharmaceuticals USASunitinib MalateTeva Pharmaceuticals USAOtherNationwide

Should you stop taking Sunitinib Malate?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.